Northern Trust
UBX

Northern Trust’s Unity Biotechnology UBX Stock Holding History

Northern Trust’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-35,452
Closed -$13.6K – 4539
2025
Q2 		$13.6K Hold
35,452
– – ﹤0.01% 4366
2025
Q1 		$36.9K Buy
35,452
+12,903
+57% +$23.3K ﹤0.01% 4275
2024
Q4 		$22K Hold
22,549
– – ﹤0.01% 4367
2024
Q3 		$33.1K Hold
22,549
– – ﹤0.01% 4273
2024
Q2 		$30.4K Sell
22,549
-30
-0.1% -$46 ﹤0.01% 4286
2024
Q1 		$37K Buy
22,579
+941
+4% +$1.63K ﹤0.01% 4267
2023
Q4 		$41.8K Hold
21,638
– – ﹤0.01% 4263
2023
Q3 		$51.9K Sell
21,638
-1,064
-5% -$2.82K ﹤0.01% 4159
2023
Q2 		$57.9K Buy
22,702
+650
+3% +$1.72K ﹤0.01% 4184
2023
Q1 		$35.9K Sell
22,052
-8,232
-27% -$33K ﹤0.01% 4336
2022
Q4 		$83K Buy
30,284
+23,664
+357% +$68.8K ﹤0.01% 4153
2022
Q3 		$26K Hold
6,620
– – ﹤0.01% 4501
2022
Q2 		$37K Hold
6,620
– – ﹤0.01% 4491
2022
Q1 		$74K Hold
6,620
– – ﹤0.01% 4439
2021
Q4 		$96K Hold
6,620
– – ﹤0.01% 4437
2021
Q3 		$198K Buy
6,620
+518
+8% +$18.3K ﹤0.01% 4185
2021
Q2 		$284K Sell
6,102
-30,582
-83% -$1.47M ﹤0.01% 3971
2021
Q1 		$2.2M Sell
36,684
-2,612
-7% -$178K ﹤0.01% 3195
2020
Q4 		$2.06M Buy
39,296
+1,192
+3% +$57.5K ﹤0.01% 3176
2020
Q3 		$1.32M Sell
38,104
-1,079
-3% -$68.3K ﹤0.01% 3256
2020
Q2 		$3.4M Buy
39,183
+6,167
+19% +$457K ﹤0.01% 2756
2020
Q1 		$1.92M Buy
33,016
+2,359
+8% +$149K ﹤0.01% 2880
2019
Q4 		$2.21M Buy
30,657
+1,599
+6% +$113K ﹤0.01% 3074
2019
Q3 		$1.77M Buy
29,058
+4,789
+20% +$339K ﹤0.01% 3165
2019
Q2 		$2.31M Buy
24,269
+576
+2% +$49K ﹤0.01% 3006
2019
Q1 		$1.92M Buy
23,693
+678
+3% +$76.9K ﹤0.01% 3110
2018
Q4 		$3.74M Buy
23,015
+17,169
+294% +$2.28M ﹤0.01% 2677
2018
Q3 		$952K Buy
5,846
+381
+7% +$62.7K ﹤0.01% 3483
2018
Q2 		$823K Buy
+5,465
New +$799K ﹤0.01% 3494

Other funds holding UBX

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

Northern Trust's UBX Position: Q3 2025 in Review

Northern Trust sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 35,452 shares — an estimated $13.6K sold.

Northern Trust first reported a position in UBX in Q2 2018 and held it in 29 quarters. The position peaked at $3.74M in Q4 2018. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

  • Northern Trust reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Northern Trust sold 35,452 Unity Biotechnology shares in Q3 2025, an estimated $13.6K.
  • Northern Trust first reported a position in Unity Biotechnology in Q2 2018 and held it in 29 quarters.
  • Northern Trust's Unity Biotechnology position peaked at $3.74M in Q4 2018.
  • 6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.